Dushon Riley, PhD

Senior Consultant

View Dushon Riley's profile on LinkedIn

Dushon is a Senior Consultant with BSP whose engagements have spanned the firm’s Medical Communications, Business and Clinical Strategy, and Health Economics practices. His recent work includes:

Medical Communications:

  • Conducted literature search and synthesis of peer-reviewed evidence to support creation of a budget impact model detailing the economic outcomes of an integrated care pathway for chronic obstructive pulmonary disease (COPD) patients
  • Developed abstracts for economic outcomes of an integrated patient management program for COPD patients for both hospital and payer stakeholder perspectives
  • Developed an abstract and poster for an international meeting showcasing the cost-effectiveness of adoption of a pharmaceutical company’s novel extended release intra-articular (IA) corticosteroid on pain relief in patients with osteoarthritis of the knee (OAK)

Business and Clinical Strategy:

  • Conducted literature analysis of arterial blood gas testing products to determine unmet needs and support a client’s domestic and international introduction of a new point-of-care testing product
  • Performed gap analysis of a client’s current clinical programs, and proposed future clinical trial design to support publication strategy and enable market penetration of a novel pressure injury support surface
  • Assessed market segmentation and opportunity, novel technology adoption likelihood, regulatory and reimbursement landscapes, and other macroeconomic factors to inform the development and launch strategies for a medical device company’s international expansion

Health Economics:

  • Constructed a budget impact model to drive the implementation of an early detection and diagnosis strategy for the treatment of chronic obstructive pulmonary disease (COPD) patients in US acute and post acute care settings
  • Supported the development of a cost-effectiveness assessment of a novel extended IA corticosteroid for pain relief in OAK patients
  • Demonstrated the economic impact of adoption of a medical device company’s pressure injury prevention surface through creation of a budget impact model and supporting publications

Dushon completed his PhD at the University of Maryland School of Medicine where he evaluated the molecular effects of stress events on cardiac calcium cycling and reactive oxygen species handling. His postdoctoral work focused on developing an early stage model of acute hyperglycemia. He recently completed a fellowship with the US Food and Drug Administration at the Center for Drug Evaluation and Research (CDER) where he conducted retrospective budget analysis and proposed a novel intramural research funding strategy. Dushon is passionate about traveling, cooking, and supporting STEM education.